Rheumatic heart disease (RHD) claims hundreds of thousands of lives each year, devastating children and young adults in low- and middle-income countries where access to specialized ultrasound equipment and refrigerated testing labs is virtually nonexistent. Inexpensive penicillin could stop the progressive valve damage if the disease is detected early, yet millions remain undiagnosed until irreversible heart failure sets in.
❓ Unknown
Researchers Develop Low-Cost Blood Test for Rheumatic Heart Disease in Resource-Poor Clinics
Just now
November 12, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
Researchers have developed a low-cost blood test for rheumatic heart disease (RHD) aimed at resource-poor clinics, which could significantly improve early detection and treatment in low- and middle-income countries, including Iran. This innovation is crucial as RHD disproportionately affects children and young adults in these regions, where access to advanced medical technology is limited.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
Just now •
Davoud Rokhbin Executed for Murder in Kashan Prison
Just now •
Ali Mokhtari Executed for Rape in Shahre Kord
Just now •
Wall Street Journal: JD Vance is Considering Meeting with Mohsen Rezaei
21 min ago •
Fires in Indonesia Burn Nearly 2.9 Million Hectares Amid Strong El Niño
23 min ago •